跳至主要内容
临床试验/CTRI/2018/04/012952
CTRI/2018/04/012952已完成3 期

Electroretinogram changes after AntiVEGF pharmacotherapy in patients with retinal vein occlusion.

Giridhar Eye Institute0 个研究点目标入组 18 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients diagnosed with RVO and has not taken any kind of treatment for the same are included in the study with a 6 months follow-up after AntiVEGF therapy

排除标准

  • (a) Intraocular surgery including cataract extraction within 6 months before enrolment (b) Co-existing other retinal diseases (c) Previous laser photocoagulation (d) Intravitreal injection of Triamcinolone acetenoid or antivascular endothelial growth factory (Anti-VEGF) agents (e) prior ocular inflammation.

研究者

相似试验